Assessment of perinatal hepatitis B and rubella prevention in New Hampshire delivery hospitals

Pediatrics

Volumn 115, Issue 5, 2005, Pages

  Bascom, Susan ^a   Miller, Stephanie ^a   Greenblatt, Jesse ^a  

^a NEW HAMPSHIRE DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

Congenital rubella syndrome; Hepatitis B surface antigen; Hepatitis B vaccine; Postpartum; Rubella; Rubella vaccine

Indexed keywords

HEPATITIS B VACCINE; RUBELLA VACCINE; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CHILD HOSPITALIZATION; COHORT ANALYSIS; CONTROLLED STUDY; DRUG TOLERANCE; FEMALE; HEPATITIS B; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL PRACTICE; MEDICAL RECORD REVIEW; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRENATAL SCREENING; PRIORITY JOURNAL; RUBELLA; ADOLESCENT; HEPATITIS B VIRUS; IMMUNOLOGY; MIDDLE AGED; NEWBORN; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PUERPERIUM; STATISTICAL MODEL; UNITED STATES;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; GUIDELINE ADHERENCE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNOGLOBULIN G; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW HAMPSHIRE; POSTPARTUM PERIOD; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; RUBELLA; RUBELLA VACCINE;

EID: 25144449232     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-2057     Document Type: Article

References (24)

1. Bath SK, Singleton JA, Strikas RA, Stevenson JM, McDonald LL, Williams WW. Performance of US hospitals on recommended screening and immunization practices for pregnant and postpartum women. Am J Infect Control. 2000;28:327-332
2. Atkinson W, Wolfe C, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 7th ed. Atlanta, GA: National Immunization Program, Centers for Disease Control and Prevention; 2002:169-189
3. McMahon BJ, Alward WLM, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis. 1985;151:599-603
4. Centers for Disease Control and Prevention. Hepatitis Surveillance Report. No. 56. Atlanta, GA: CDC; 1996
5. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1991;40:1-25
6. Centers for Disease Control and Prevention. Recommendations of the Immunization Practices Advisory Committee prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen. MMWR. 1988;37:341-346, 351
7. Centers for Disease Control and Prevention. Recommendations of the Immunization Practices Advisory Committee (ACIP): Rubella prevention. MMWR Morb Mortal Wkly Rep. 1981;30:37- 42,47
8. Atkinson W, Wolfe C, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 7th ed. Atlanta, GA: National Immunization Program, Centers for Disease Control and Prevention; 2002:124-138
9. Orenstein WA, Bart KJ, Hinman AR, et al. The opportunity and obligation to eliminate rubella from the United States. JAMA. 1984;251:1988-1994
10. Healthy people 2010. Conference ed., vol 1, objective 14-1i:14-11. Washington, DC: US Department of Health and Human Services; January 2000. Available at: www.health.gov/healthypeople/document/html/volume1/14immunization. htm
11. Dykewicz CA, Kruszon-Moran D, McQuillan GM, et al. Rubella seropositivity in the United States, 1988-1994. Clin Infect Dis. 2001;33:1279-1286
12. Wexler DL. Give the birth dose . . . hepatitis B vaccine at birth saves lives! 2002. Available at: www.immunize.org/catg.d/p2125.pdf. Accessed March 18, 2005
13. Yusuf HR, Daniels D, Smith P, Coronado V, Rodewald L. Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series. JAMA. 2000;284:978-983
14. Centers for Disease Control and Prevention. Notice to readers: recommended childhood immunization schedule - United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:31-33
15. Centers for Disease Control and Prevention. Notice to readers: thimerosal in vaccine: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morb Mortal Wkly Rep. 1999;48:563-565
16. Centers for Disease Control and Prevention. Notice to readers: availability of hepatitis B vaccine that does not contain thimerosal as a preservative. MMWR Morb Mortal Wkly Rep. 1999;48:780-782
17. Hurie MB, Saari TN, Davis JP. Impact of the joint statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices. Pediatrics. 2001;107:755-758
18. Oram RJ, Daum RS, Seal JB, Lauderdale DS. Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine. JAMA. 2001;285:1874-1879
19. Clark SJ, Cabana MD, Malik T, Yusuf H, Freed GL. Hepatitis B vaccination practices in hospital newborn nurseries before and after changes in vaccination recommendations. Arch Pediatr Adolesc Med. 2001;155:915-920
20. Schrag SJ, Arnold KE, Mohle-Boetani JC, et al. Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol. 2003;102:753-760
21. Centers for Disease Control and Prevention. Rubella and congenital rubella syndrome - United States, 1994-1997. MMWR Morb Mortal Wkly Rep. 1997;46:350-354
22. Centers for Disease Control and Prevention. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR Morb Mortal Wkly Rep. 2001;50:1-23
23. Simpson DM. Forty years and four surveys: how does our measuring measure up? Am J Prev Med. 2001;20(suppl):6-14
24. Cheldelin LAV, Francis DP, Tilson H. Postpartum rubella vaccination. A survey of private physicians in Oregon. JAMA. 1973;225:158-159